GlassScriptPhysician profile
Carlos Wade
NPI 1598782062
$1,851.94
in general payments reported to CMS, 2019-2025
22 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $207 · 2021: $248 · 2022: $267 · 2023: $267 · 2024: $342 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $295.22 | 2019-2025 | Renasys Touch, Grafix Pl |
| Tactile Systems Technology INC | $250.68 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Kci USA, INC. | $241.13 | 2019-2020 | |
| Cashflow Solutions, LLC | $194.15 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Misonix INC | $191.07 | 2019-2021 | |
| Kerecis Limited | $89.96 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $74.04 | 2021-2024 | Nuzyra |
| Lifenet Health | $72.07 | 2023-2025 | Theragenesis Wound Matrix |
| Abbvie INC. | $69.62 | 2021-2025 | |
| Integra Lifesciences Corporation | $54.83 | 2022 | |
| Urgo Medical North America, LLC | $53.62 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Next Science LLC | $45.37 | 2023-2024 | Xperience, Blastx, Surgx |
| Convatec INC. | $41.55 | 2021-2022 | |
| Mimedx Group, INC. | $31.75 | 2024 | |
| Organogenesis INC. | $29.10 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $23.18 | 2022 | |
| Hydrofera LLC | $19.02 | 2021 | |
| Reapplix INC. | $18.05 | 2021 | |
| Solventum Corporation | $17.33 | 2025 | Activ.A.C. |
| Reddress USA, INC. | $14.12 | 2021 | |
| Bsn Medical INC | $13.77 | 2024 | |
| Melinta Therapeutics, LLC | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.